SCHEMBL3034652

SCHEMBL3034652

NC(=O)c1ccc(-c2cccc(C(=O)NCc3cccc(C(F)(F)F)c3)c2O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
PLA2G1B P04054 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
GAA P10253 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ATG4B Q9Y4P1 1/20 0.56
LMNA P02545 1/20 0.55
HPGD P15428 1/20 0.55
MAPK14 Q16539 1/20 0.52
MAOB P27338 1/20 0.50
PPARG P37231 1/20 0.50
CNR2 P34972 1/20 0.49
MAPK1 P28482 1/20 0.49
BACE1 P56817 1/20 0.49
MTTP P55157 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3023775 0.90 MAOB (0.48) MLYCDMEN1KMT2APLA2G1BCYP1A2
SCHEMBL3036995 0.83 P2RX1 (0.58) MEN1KMT2A
SCHEMBL3025881 0.81 RAB9A (0.61) KMT2ACYP3A4CYP2D6LMNAHPGD
SCHEMBL3037017 0.78 HTT (0.64) KMT2ACYP1A2CYP3A4GAACYP2C19
SCHEMBL3018099 0.78 PLAU (0.61) MEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL6171274 0.77 MLYCD (0.67) MLYCDMEN1KMT2APLA2G1BCYP1A2
SCHEMBL5227678 0.76 MLYCD (0.86) MLYCDMEN1KMT2APLA2G1BCYP1A2
SCHEMBL31414549 0.76 MLYCD (0.56) MLYCDMEN1KMT2APLA2G1BCYP1A2
SCHEMBL3025996 0.76 RAB9A (0.57) MEN1KMT2ACYP1A2CYP3A4GAA
SCHEMBL4495476 0.75 MLYCD (0.80) MLYCDMEN1KMT2APLA2G1BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 MLYCD 1861/4885MEN1 2346/4885KMT2A 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.